IPFrontline: Consero’s IP Forum for Pharmaceuticals & Biotechnology to Assess Lessons from 2015’s Key Supreme and District Court Cases

Originally Published in IP Frontline | November 12, 2015

With 2016 approaching, Chief IP and Patent Counsel will convene for Consero’s IP Forum for Pharmaceuticals & Biotechnology to examine the lessons learned from the most significant judicial decisions of 2015. The Forum, hosted by Consero, an international leader in developing high-level, invitation-only events for senior executives, will be held December 6-8 at the Biltmore Miami Coral Gables in Miami, Florida.

“In this time of changing patent law, pharmaceutical and biotechnology executives’ IP strategies must be flexible, aggressive, and fully attuned to the latest developments from the courts,” said Paul Mandell, Founder & CEO of Consero. “Consero’s 2015 IP Forum for Pharmaceuticals & Biotechnology will provide an opportunity for Chief IP and Chief Patent Counsel to review key court cases of 2015, as well as share best practices and strategies that will help them to lead their departments and companies in the right direction in the year ahead.”

“The Forum will review the implications of 2015’s key rulings that impact companies’ global IP portfolios,” said Jessica Druckman, Founder & SVP of Program Development at Consero. “We will explore top-of-mind issues, including what upcoming cases Chief IP and Patent Counsel should be aware of, and how those cases can potentially affect overall IP strategy.”

Additional topics will include:

  • Smart Partnering: Working in Tandem with Institutes of Higher Learning – This session will advise on what factors lead to successful partnerships with higher education institutions, what pitfalls can result form such ventures and how to evaluate the ROI of these relationships.
  • Strategy Session: What Is Your IP Master Plan? – In this session, executives will discuss how to plan out IP strategy over the next five years and how to safeguard short- and long-term IP strategy while maintaining the flexibility to respond to IP issues as they arise.
  • Putting on Your Business Hat: Integrating IP into the Corporate Strategy – Executives will evaluate strategies for effectively communicating the inner workings of patent strategy to those in the company who lack a legal background, as well as fully incorporating the IP team and outside counsel into the business.